Brian Matthew Wolpin
Brigham and Women's Hospital · 1,247 works · 31,425 citations · h-index 91
Top works
- Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- Detectable clonal mosaicism and its relationship to aging and cancer
- Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
- Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
- A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
- ABO Blood Group and the Risk of Pancreatic Cancer
- Pancreatic Adenocarcinoma, Version 2.2014
- Systemic Treatment of Colorectal Cancer
- 652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
- Pancreatic Adenocarcinoma, Version 2.2012
- Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras -driven cancers
- Adjuvant Treatment of Colorectal Cancer
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
- Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019
- Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
- ABO Blood Group and Risk of Coronary Heart Disease in Two Prospective Cohort Studies
- Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas